Biocon is currently trading at Rs. 479.15, up by 12.25 points or 2.62% from its previous closing of Rs. 466.90 on the BSE.
The scrip opened at Rs. 477.00 and has touched a high and low of Rs. 484.90 and Rs. 471.00 respectively. So far 265622 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 513.65 on 21-Apr-2014 and a 52 week low of Rs. 264.45 on 13-Jun-2013.
Last one week high and low of the scrip stood at Rs. 513.65 and Rs. 451.65 respectively. The current market cap of the company is Rs. 9563.00 crore.
The promoters holding in the company stood at 60.97% while Institutions and Non-Institutions held 19.58% and 19.44% respectively.
Biocon has reported results for fourth quarter and year ended March 31, 2014
The company has posted a rise of 126.53% in its net profit at Rs 86.74 crore for the quarter ended March 31, 2014 as compared to Rs 38.29 crore for the same quarter in the previous year. Total income of the company has increased by 20.25% at Rs 582.53 crore for quarter under review as compared to Rs 484.40 crore for the quarter ended March 31, 2013.
On consolidated basis, the company has reported 54.51% fall in its net profit at Rs 113.08 crore for the quarter ended March 31, 2014 as compared to Rs 248.61 crore for the same quarter in the previous year. However, total income of the company has soared by 14.92% at Rs 745.77 crore for quarter under review as compared to Rs 648.93 crore for the quarter ended March 31, 2013.
For the year ended March 31, 2014, the group has posted a jump of 19.64% in its net profit at Rs 329.85 crore as compared to Rs 275.7 crore for the same period in the previous year. Total income of company has surged by 13.75% at Rs 2263.08 crore for year under review as compared to Rs 1989.47 crore for the period ended March 31, 2013.
For the year ended March 31, 2014, on the consolidated basis, the group has reported 18.69% fall in its net profit at Rs 413.72 crore as compared to Rs 508.82 crore for the same period in the previous year. However, total income of company has increased by 15.57% at Rs 2933.19 crore for year under review as compared to Rs 2537.96 crore for the period ended March 31, 2013.
|
Friday, 25 April 2014
Biocon surges on reporting twofold jump in Q4 standalone net profit
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment